4//SEC Filing
Elling Christian E 4
Accession 0001140361-23-039346
CIK 0001865494other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 9:24 PM ET
Size
7.3 KB
Accession
0001140361-23-039346
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Elling Christian E
Director
Transactions
- Award
Common Stock
2023-08-09$1.90/sh+7,901,234$15,012,345→ 13,950,686 total(indirect: Lundbeckfond Invest A/S) - Award
Warrants (Right to Buy)
2023-08-09$0.13/sh+7,901,234$987,654→ 7,901,234 total(indirect: Lundbeckfond Invest A/S)Exercise: $2.47From: 2023-08-09→ Common Stock (7,901,234 underlying)
Footnotes (2)
- [F1]The securities are held of record by Lundbeckfond Invest A/S. The Reporting Person is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S. The Reporting Person disclaims beneficial ownership of the securities held by Lundbeckfond Invest A/S except to the extent of his pecuniary interest therein, if any.
- [F2]These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023).
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001891306
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 9:24 PM ET
- Size
- 7.3 KB